Comments
Drug firm Claris Lifesciences has received approval by the UK health regulator, Medicines and Healthcare products Regulatory Agency (MHRA) for its newly commissioned plant in Ahmedabad.
“This is the first regulatory inspection and compliance approval conducted by MHRA—UK in line with the EU GMP regulations for plant 2,” Claris Lifesciences said in a filing on BSE.
This approval is for products presented in glass ampoules manufactured in line 1 of plant 2, it added.
“This will help in enhancing capacities to grow in regulated markets, especially the European Union. The company’s speciality injectables business saw a growth of 30 per cent in the last quarter,” Claris Lifesciences said.
The company’s plant 1 is already approved by MHRA—UK, it added.
Ahmedabad based Claris Lifesciences is a sterile injectables pharmaceutical company with a market presence across 100 countries worldwide.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.